prolyl-glycyl-proline and Cystic-Fibrosis

prolyl-glycyl-proline has been researched along with Cystic-Fibrosis* in 2 studies

Other Studies

2 other study(ies) available for prolyl-glycyl-proline and Cystic-Fibrosis

ArticleYear
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020, Volume: 19, Issue:1

    Proline-glycine-proline (PGP) is a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP-9) and prolylendopeptidase (PE), and capable of eliciting neutrophil chemotaxis and epithelial remodelling. PGP is normally then degraded by leukotriene A. Broncho-alveolar lavage (BAL) fluid was obtained from 38 CF (9 newborns and 29 older children) and 24 non-CF children. BAL cell differentials and levels of PGP, MMP-9, PE and LTA. Whilst PGP was present in all but one of the older CF children tested, it was absent in non-CF controls and the vast majority of CF newborns. BAL levels of MMP-9 and PE were elevated in older children with CF relative to CF newborns and non-CF controls, correlating with airway neutrophilia and supportive of PGP generation. Furthermore, despite extracellular LTA. A striking imbalance between PGP-generating and -degrading enzymes enables PGP accumulation in CF children from early life and potentially supports airway neutrophilia.

    Topics: Airway Remodeling; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chemotaxis, Leukocyte; Child; Cystic Fibrosis; Female; Humans; Infant, Newborn; Inflammation; Leukocyte Elastase; Male; Matrix Metalloproteinase 9; Neutrophils; Oligopeptides; Proline; Prolyl Oligopeptidases; Sputum

2020
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Apr-15, Volume: 180, Issue:8

    Chronic neutrophilic inflammation is a manifestation of a variety of lung diseases including cystic fibrosis (CF). There is increasing evidence that fragments of extracellular matrix proteins, such as collagen and elastin, play an important role in inflammatory cell recruitment to the lung in animal models of airway inflammation. Unfortunately, the association of these peptides with human disease and the identification of therapeutic targets directed toward these inflammatory pathways have remained elusive. In this study, we demonstrate that a novel extracellular matrix-derived neutrophil chemoattractant, proline-glycine-proline (PGP), acts through CXC receptors 1 and 2 on neutrophils, similar to N-acetylated proline-glycine-proline (N-alpha-PGP). We describe the specific multistep proteolytic pathway involved in PGP generation from collagen, involving matrix metalloproteases 8 and 9 and prolyl endopeptidase, a serine protease for which we identify a novel role in inflammation. PGP generation correlates closely with airway neutrophil counts after administration of proteases in vivo. Using CF as a model, we show that CF sputum has elevated levels of PGP peptides and that PGP levels decline during the course of CF inpatient therapy for acute pulmonary exacerbation, pointing to its role as a novel biomarker for this disease. Finally, we demonstrate that CF secretions are capable of generating PGP from collagen ex vivo and that this generation is significantly attenuated by the use of inhibitors directed toward matrix metalloprotease 8, matrix metalloprotease 9, or prolyl endopeptidase. These experiments highlight unique protease interactions with structural proteins regulating innate immunity and support a role for these peptides as novel biomarkers and therapeutic targets for chronic, neutrophilic lung diseases.

    Topics: Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Chronic Disease; Cystic Fibrosis; Extracellular Matrix; Extracellular Matrix Proteins; Humans; Inflammation; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Mice; Neutrophil Activation; Neutrophils; Oligopeptides; Proline; Prolyl Oligopeptidases; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Serine Endopeptidases; Sputum

2008